Stock Market News8 hours Gilead: A Large-Cap Pharma With Limited Patent Cliff Exposure Seeking Alpha
Gilead: A Large-Cap Pharma With Limited Patent Cliff Exposure.
X2 days GILD Obtains Positive CHMP Opinion for Liver Disease Drug Zacks
X2 days Gilead (GILD) Upgraded to Buy: Here’s Why Zacks
X5 days Gilead Sciences (GILD) Stock Moves -0.57%: What You Should Know Zacks
X6 days Gilead appoints Sanofi official Dietmar Berger as next chief medical officer Investing.com
X6 days Is Gilead Sciences (GILD) Stock Undervalued Right Now? Zacks
X6 days Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It Zacks
X1 week Final Trade: LMAT, GOOGL, IBM, GILD YouTube
X1 week The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks
X1 week Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks
X2 weeks Gilead Sciences Is Turning Itself Around. Why Its Stock Can Keep Rallying. Yahoo Finance
X2 weeks Gilead Sciences, Inc. (GILD) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript) Seeking Alpha
X2 weeks Gilead Collaborates With German Biotech Tubulis for Solid Tumor ADC Zacks
X2 weeks Gilead Sciences, Inc. (GILD) Piper Sandler 36th Annual Healthcare Conference (Transcript) Seeking Alpha
X2 weeks Is Gilead (GILD) a Buy as Wall Street Analysts Look Optimistic? Zacks
X3 weeks Gilead Stock Surges 44.2% in 6 Months: Time to Buy or Sell? Zacks
X3 weeks GILD vs. VRTX: Which Stock Should Value Investors Buy Now? Zacks
X3 weeks Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know Zacks
X4 weeks Gilead Sciences, Inc. (GILD) Jefferies London Healthcare Conference (Transcript) Seeking Alpha
X4 weeks Market Digest: ADTN, EQR, GILD, NFG, PRU, MSCI Yahoo Finance
X1 month Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet Zacks
X1 month GILD or VRTX: Which Is the Better Value Stock Right Now? Zacks
X1 month Gilead increases 2024 outlook, expects new drug filing by end of year Yahoo Finance
X1 month Gilead Beats on Q3 Earnings and Sales, Raises Annual Outlook Zacks
X1 month Why Gilead’s Solid Q3 Earnings Could Point To A Dividend Surprise Next Year Seeking Alpha
X1 month Gilead Sprints To A Profit-Taking Zone After Riding Covid Drug To Beat And Raise Investor's Business Daily
X1 month Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidance MarketWatch
X1 month Gilead Science to Report Q3 Earnings: What’s in the Cards? Zacks
X2 months Gilead Sciences (GILD) Gains As Market Dips: What You Should Know Zacks
X2 months Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by New York State Teachers Retirement System MarketBeat
X2 months Earnings Preview: Gilead Sciences (GILD) Q3 Earnings Expected to Decline Zacks
X2 months Gilead Sciences (GILD) Stock Sinks As Market Gains: Here’s Why Zacks
X2 months Gilead Sciences (NASDAQ:GILD) Given Sector Perform Rating at Royal Bank of Canada MarketBeat
X2 months Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of “Moderate Buy” by Brokerages MarketBeat
X2 months Why Gilead Sciences (GILD) Dipped More Than Broader Market Today Zacks
X2 months Gilead Sciences (NASDAQ:GILD) Sets New 12-Month High – Still a Buy? MarketBeat
X2 months Gilead Sciences (NASDAQ:GILD) Stock Rating Upgraded by Leerink Partnrs MarketBeat
X2 months Gilead, MRK Report Data From Investigational Combination Study for HIV Zacks
X2 months Calls of the Day: Gilead, Berkshire Hathaway and SLB YouTube
X2 months Crew Capital Management Ltd. Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD) MarketBeat
X2 months Gilead Sciences (NASDAQ:GILD) Upgraded by Leerink Partners to Outperform MarketBeat
X2 months Stratos Investment Management LLC Lowers Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD) MarketBeat
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.